accessed from methyl ester 5, which could be derived from the amino acid D-allo-threonine (6) .
An initial challenge to this synthesis plan was the limited commercial availability of D-allothreonine 6.7 Given the potential utility of this amino acid in organic synthesis, it was not surprising that several methods are available for its preparation.8 Despite the availability of these methods, we were interested in devising a more efficient strategy to access this important amino acid. Specifically, we sought to develop a strategy where L-threonine 7 could be epimerized at the amino strereocenter to provide the desired D-allo-threonine configuration since 7 is readily available (Scheme 2).
Our revised plan was to start the synthesis route outlined in Scheme 1 with L-threonine (7) instead of its more expensive diastereomer 6. We surmised that the enolate of the Lthreonine-derived oxazolidine 8 would be protonated from the si-face, providing the desired configuration at the amino streocenter. This epimerization strategy offered 2 distinct advantages over the approaches previously reported in the literature. First, our synthesis would begin from 7, a cheap and readily available starting material. Second, this strategy provides an alternative to undertaking a separate synthesis to procure multigram quantities of D-allo-threonine by utilizing an intermediate in our proposed route to the target glycal 3.
Towards this end, L-threonine was readily converted to oxazolidine 8 (Scheme 3). Initially, we chose to carry out a control experiment to test the feasibility of the approach outlined in Scheme 2. Oxazolidine 8 was treated with LDA at −78 °C followed by exposure to MeI. The purpose of using MeI in this control experiment was twofold. While serving to confirm the facial selectivity of the alkylation (and ultimately, the protonation), this experiment would also allow us to unambiguously confirm if enolization was achieved.9 Surprisingly, after oxazolidine 8 was treated with LDA at −78 °C followed by MeI the starting material was recovered unchanged.
Though we acknowledged the possibility that the enolate was too hindered to be alkylated with MeI, we considered this scenario to be unlikely.10 It seemed more probable that the enolate had not been formed. This observation can be rationalized by considering possible conformations of oxazolidine 8 (Figure 2 ). An important consideration to the following analysis is that the carbamate will possess double bond character. In conformer I, the hydrogen α to the ester is placed in plane with the carbamate in order to minimize allylic strain. This forces the ester into a pseudo-axial position and introduces an unfavorable synpentane interaction between the ester and the methyl substituent cis to the ester. An alternative conformer (II) is one in which the ester is placed in a pseudo-equatorial position, thereby alleviating the syn-pentane interaction. However, in order to minimize unfavorable steric interactions with the carbamate, the ester rotates about the C-C bond (shown in red). As a consequence of this bond rotation, the α-hydrogen is no longer stereoelectronically aligned for deprotonation.
This conformational analysis indicates that enolization will only take place if conformer I could be accessed. Using this analysis as a guide we sought to redesign the substrate such that the syn-pentane interaction would be alleviated. We rationalized this would be done most effectively by replacing the methyl group cis to the methyl ester with a proton.
Towards that end, methyl ester 9 was treated with pivaldehyde under acidic conditions to afford oxazolidine 10 (Scheme 4). With the syn-pentane interaction now removed, we were pleased to discover that exposure of 10 to LDA followed by a reverse quench with AcOH/ MeOH afforded the fully epimerized product in quantitative yield.11 This result strongly supports the assertion that enolization was precluded because of unfavorable non-covalent interactions described in Figure 2 .
After the successful epimerization12 of 10, oxazolidine 11 was converted to a Weinreb amide followed by treatment with ethynyl Grignard (Scheme 5). The ynone 12 was reduced to the corresponding propargyl alcohol with NaBH 4 .13 The resulting carbinol was protected as a TIPS ether and the oxazolidine was cleaved under acidic conditions. The resulting alkynol underwent cycloisomerization14 in the presence of Wilkinson's catalyst to provide glycal 3 in 76% yield.15
In conclusion, we have developed an efficient synthesis of the N-(tert-butyloxycarbonyl)-Otriisopropylsilyl-D-pyrrolosamine glycal of lomaiviticin A (1) and lomaiviticin B (2). Our synthesis is highlighted by the epimerization of the L-threonine derived oxazolidine 10 to oxazolidine 11, which possesses the desired relative configuration. This epimerization reaction was made possible only after control experiments indicated substituted oxazolidines may adopt conformations that preclude enolization. Glycal 3 will ultimately be converted to a suitable glycosyl donor for the glycosylation of the aglycones of 1 and 2. These results will be reported in due course. 
